You have 0 items in your cart
Introduction
SS-31 is a synthetic peptide that has attracted significant scientific interest because of its interaction with mitochondria, the structures responsible for producing energy within cells. Although SS-31 is now widely discussed in peptide research, relatively few people know how it was developed or the scientists responsible for its discovery.
Understanding the origins of SS-31 provides valuable insight into the evolution of mitochondrial research and peptide engineering. This article explores the history of SS-31, the researchers behind its development, and why it continues to be studied in laboratories around the world.
This article is intended for educational purposes and discusses the scientific history of a research peptide.
Who Discovered SS-31?
SS-31 was developed by researchers led by Dr Hazel H. Szeto, a physician-scientist whose work focused on designing small peptides capable of targeting mitochondria.
The peptide belongs to a family of compounds often referred to as Szeto–Schiller (SS) peptides, named after Dr Hazel Szeto and collaborator Dr Peter Schiller, whose research helped establish this important area of peptide science.
Their work represented a significant advance in understanding how specifically engineered peptides could interact with mitochondria.
Why Was SS-31 Developed?
Scientists were interested in creating small, stable peptides capable of reaching mitochondria and investigating mitochondrial biology more effectively.
Developing compounds that could selectively interact with these cellular structures opened new opportunities for studying:
- Mitochondrial function
- Cellular bioenergetics
- Peptide chemistry
- Molecular signalling
- Oxidative biology
- Cell physiology
This work contributed to a broader understanding of how mitochondria influence cellular processes.
The Development of Szeto–Schiller Peptides
Rather than producing a single molecule, researchers developed a family of related peptides designed to investigate mitochondrial biology.
Each peptide was carefully engineered to optimise characteristics such as:
- Molecular size
- Structural stability
- Cellular uptake
- Mitochondrial localisation
- Analytical consistency
SS-31 emerged as one of the most extensively investigated members of this peptide family.
Why Is SS-31 Important in Scientific Research?
The discovery of SS-31 helped expand scientific knowledge of mitochondrial biology and demonstrated how peptide engineering could be used to investigate highly specialised cellular structures.
Research involving SS-31 has contributed to studies in:
- Mitochondrial science
- Cell biology
- Peptide engineering
- Molecular pharmacology
- Protein interactions
- Structure–activity relationships
Its development also encouraged further investigation into mitochondria-targeted peptides.
Ongoing Scientific Interest
Scientists continue to investigate SS-31 using increasingly advanced analytical methods.
Current areas of research include:
- Mitochondrial signalling
- Cellular energy biology
- Peptide stability
- Molecular interactions
- Laboratory analytical techniques
- Peptide design
As mitochondrial research continues to evolve, SS-31 remains an important compound for investigating these complex biological systems.
Frequently Asked Questions
Who discovered SS-31?
SS-31 was developed by researchers led by Dr Hazel H. Szeto and forms part of the Szeto–Schiller family of mitochondria-targeting peptides.
Why is it called SS-31?
The “SS” designation refers to the Szeto–Schiller peptide family, named after the scientists involved in its development.
Is SS-31 naturally occurring?
No. SS-31 is a synthetic peptide created through peptide engineering for scientific research.
Why is SS-31 still studied?
Researchers continue to investigate SS-31 to improve understanding of mitochondrial biology, peptide chemistry and cellular signalling.
Conclusion
The development of SS-31 marked an important step forward in mitochondrial peptide research. Through the work of Dr Hazel Szeto, Dr Peter Schiller and their colleagues, scientists created a peptide that continues to contribute to research into mitochondrial function, peptide engineering and cellular biology.
Understanding who developed SS-31 provides valuable historical context for researchers exploring the continuing evolution of mitochondrial science and synthetic peptide design.
This article is provided for educational and scientific purposes only. It discusses the scientific history of a research peptide and is not intended as medical advice or guidance on clinical use.